Bernd Jilma
#133,127
Most Influential Person Now
Researcher
Bernd Jilma's AcademicInfluence.com Rankings
Bernd Jilmacomputer-science Degrees
Computer Science
#5961
World Rank
#6286
Historical Rank
Machine Learning
#1780
World Rank
#1803
Historical Rank
Artificial Intelligence
#2026
World Rank
#2060
Historical Rank
Database
#3085
World Rank
#3215
Historical Rank

Download Badge
Computer Science
Bernd Jilma's Degrees
- PhD Computer Science University of Vienna
- Masters Computer Science University of Vienna
- Bachelors Computer Science University of Vienna
Similar Degrees You Can Earn
Why Is Bernd Jilma Influential?
(Suggest an Edit or Addition)Bernd Jilma's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. (2009) (423)
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. (2016) (396)
- Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes (2008) (350)
- Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. (2004) (330)
- Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (2000) (303)
- Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis (2020) (294)
- Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. (2001) (280)
- Calcium channel blockers reduce the antiplatelet effect of clopidogrel (2008) (272)
- Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction (2004) (246)
- Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial (2015) (239)
- Monitoring of Aspirin (ASA) Pharmacodynamics with the Platelet Function Analyzer PFA-100® (2000) (216)
- A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes (2006) (211)
- Paroxetine decreases platelet serotonin storage and platelet function in human beings (2000) (211)
- Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. (1999) (211)
- Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. (2015) (196)
- Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. (2014) (194)
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. (2019) (191)
- Challenges with advanced therapy medicinal products and how to meet them (2010) (191)
- Interspecies differences in coagulation profile (2008) (174)
- Effects of carbon monoxide inhalation during experimental endotoxemia in humans. (2005) (174)
- Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial (2007) (171)
- Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans (2006) (162)
- Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. (1997) (156)
- Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta‐analysis (2010) (141)
- Heparin blunts endotoxin-induced coagulation activation. (1999) (137)
- Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells. (2019) (136)
- Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. (2006) (134)
- Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (2003) (134)
- Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator‐stimulated phosphoprotein phosphorylation assay (2010) (131)
- Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. (2003) (128)
- Platelet dysfunction in outpatients with left ventricular assist devices. (2009) (125)
- Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS (2006) (124)
- Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. (1997) (122)
- In vivo profile of the human leukocyte microRNA response to endotoxemia. (2009) (122)
- Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation (2005) (120)
- Elevated Circulating P-Selectin in Insulin Dependent Diabetes Mellitus (1996) (120)
- Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. (2013) (118)
- Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases (2010) (118)
- Thrombin as a multi-functional enzyme (2011) (112)
- Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. (1996) (111)
- Evidence of a U‐shaped association between factor XII activity and overall survival (2007) (107)
- Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS‐PCI study (2012) (104)
- Altered platelet plug formation in hyperthyroidism and hypothyroidism. (2007) (103)
- VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP (2014) (99)
- Effects of Endotoxemia on Thrombopoiesis in Men (1999) (96)
- Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site (2017) (95)
- Sex differences in HAART-associated dyslipidaemia (2001) (87)
- Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. (2008) (85)
- Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura (2010) (83)
- Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia (2004) (81)
- Initial experience from a double‐blind, placebo‐controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura (2012) (78)
- Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration (2020) (78)
- Effects of endothelin-1 (ET-1) on ocular hemodynamics. (1997) (77)
- High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men (2005) (77)
- Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis (2010) (76)
- A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura (2011) (76)
- Effects of desmopressin on circulating P‐selectin (1996) (76)
- Targeting von Willebrand factor and platelet glycoprotein Ib receptor (2010) (74)
- Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans (2016) (73)
- Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen. (1999) (73)
- Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. (2008) (73)
- Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans (2002) (72)
- A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease (2010) (72)
- Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation (2004) (72)
- Acetaminophen has Greater Antipyretic Efficacy than Aspirin in Endotoxemia: A Randomized, Double‐Blind, Placebo‐Controlled Trial (1999) (71)
- Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors. (2016) (69)
- Lepirudin blunts endotoxin-induced coagulation activation. (2000) (69)
- Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. (2019) (69)
- Pharmacokinetics, pharmacodynamics and safety of aptamers (2018) (68)
- Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers (2016) (67)
- Plasma protein profiling: Unique and stable features of individuals (2005) (67)
- Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C. (2009) (67)
- A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection. (2020) (66)
- Impaired Platelet Function among Platelet Donors (2001) (65)
- Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) (2020) (65)
- The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. (2004) (65)
- The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediated ex vivo platelet function in acute myocardial infarction (2009) (63)
- Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups (2019) (62)
- A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers (2014) (62)
- Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids. (2009) (61)
- Duffy antigen modifies the chemokine response in human endotoxemia (2008) (61)
- Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers (2015) (61)
- A Randomized, Controlled Trial of the Effects of Adding Vitamin B12 and Folate to Erythropoietin for the Treatment of Anemia of Prematurity (2006) (61)
- Role of von Willebrand factor in vascular disease (2009) (60)
- Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia (2006) (60)
- Anti–von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura (2009) (59)
- Cross validation of the Multiple Electrode Aggregometry (2009) (58)
- Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. (1998) (58)
- Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia (2003) (58)
- Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers. (2016) (57)
- Effects of estradiol on circulating P-selectin. (1996) (57)
- Endotoxaemia modulates Toll‐like receptors on leucocytes in humans (2003) (57)
- Differential induction of P‐selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P‐selectin (1998) (57)
- Comparison of the Effects of Ketamine and Memantine on Prolactin and Cortisol Release in Men: A Randomized, Double-blind, Placebo-controlled Trial (2001) (56)
- The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. (2005) (56)
- Dexamethasone down‐regulates the expression of L‐selectin on the surface of neutrophils and lymphocytes in humans* (1997) (56)
- Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma (2012) (56)
- Sutimlimab in Cold Agglutinin Disease. (2021) (56)
- Effect of Fortifiers and Additional Protein on the Osmolarity of Human Milk: Is It Still Safe for the Premature Infant? (2013) (55)
- Effects of exercise on circulating vascular adhesion molecules in healthy men. (1997) (55)
- Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans (1999) (55)
- Effects of 17 beta-estradiol on circulating adhesion molecules. (1994) (54)
- The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease (2012) (54)
- Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. (1997) (54)
- Fy phenotype and gender determine plasma levels of monocyte chemotactic protein (2001) (54)
- Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. (2002) (53)
- ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion (2012) (53)
- Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine. (2010) (52)
- Anti‐C1s monoclonal antibody BIVV009 in late antibody‐mediated kidney allograft rejection—results from a first‐in‐patient phase 1 trial (2018) (51)
- D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study. (2015) (51)
- The aptamer ARC1779 blocks von Willebrand factor–dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo (2010) (51)
- Circadian variation of granulocyte colony stimulating factor levels in man (1999) (50)
- Effects of a Combined Therapy of Erythropoietin, Iron, Folate, and Vitamin B12 on the Transfusion Requirements of Extremely Low Birth Weight Infants (2006) (50)
- Chikungunya vaccines in development (2015) (50)
- Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. (2011) (50)
- Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51. (2011) (49)
- Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration (2011) (48)
- Expression of the High-Affinity IgG Receptor FcRI (CD64) in Patients With Inflammatory Bowel Disease: A New Biomarker for Gastroenterologic Diagnostics (2009) (46)
- Procoagulant microparticles promote coagulation in a factor XI‐dependent manner in human endotoxemia (2016) (46)
- Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent. (2016) (46)
- Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial (2019) (45)
- Systemic inflammation increases shear stress‐induced platelet plug formation measured by the PFA‐100 (2000) (44)
- Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. (2008) (44)
- Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients. (2007) (44)
- Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients. (1999) (43)
- Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. (2013) (42)
- Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. (2004) (42)
- Partial Blockade of Nitric Oxide Synthase Blunts the Exercise-induced Increase of von Willebrand Factor Antigen and of Factor VIII in Man (1997) (41)
- A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia–reperfusion injury and inflammation after on‐pump coronary artery bypass graft surgery (2015) (40)
- The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention. (2015) (40)
- Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis (2013) (40)
- Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity (2004) (39)
- Small Volume Enemas Do Not Accelerate Meconium Evacuation in Very Low Birth Weight Infants (2007) (39)
- Regulation of Fas (APO-1, CD95) and Fas Ligand Expression in Leukocytes During Systemic Inflammation in Humans (2003) (39)
- The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation. (2009) (39)
- A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway (2018) (39)
- Potential diagnostic markers for disseminated intravascular coagulation of sepsis. (2016) (38)
- Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia (2018) (38)
- Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia (2010) (37)
- The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. (2006) (37)
- Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis (1998) (36)
- Acenocoumarol decreases tissue factor–dependent coagulation during systemic inflammation in humans (2002) (36)
- Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. (2003) (36)
- Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. (2008) (36)
- Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans (2003) (36)
- O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. (2009) (35)
- Endotoxin down-modulates granulocyte colony-stimulating factor receptor (CD114) on human neutrophils. (2000) (35)
- Putative role of adhesion molecules in metabolic disorders. (1997) (35)
- Human Milk Analyser shows that the lactation period affects protein levels in preterm breastmilk (2016) (35)
- Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib (2016) (35)
- Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions (2015) (34)
- The Effect of an Osmotic Contrast Agent on Complete Meconium Evacuation in Preterm Infants (2012) (34)
- Effects of low dose endotoxemia on endothelial progenitor cells in humans. (2007) (34)
- Coagulation interventions in experimental human endotoxemia. (2006) (34)
- Effects of angiotensin-II infusion at pressor and subpressor doses on endothelin-1 plasma levels in healthy men. (1997) (34)
- Detecting aspirin resistance with the platelet function analyzer (PFA-100). (2001) (33)
- Reproducibility and standardized reporting of the vasodilator-stimulated phosphoprotein phosphorylation assay (2008) (33)
- Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina (2017) (33)
- Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial. (2004) (33)
- Glucocorticoids dose-dependently increase plasma levels of granulocyte colony stimulating factor in man. (1998) (33)
- Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA‐100 (2004) (33)
- Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study (2020) (33)
- Massive pulmonary embolism leading to cardiac arrest is associated with consumptive coagulopathy presenting as disseminated intravascular coagulation (2010) (32)
- Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation (2015) (32)
- Racial differences in endotoxin‐induced tissue factor‐triggered coagulation (2009) (32)
- Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia (2018) (32)
- Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. (2002) (32)
- Effects of anticoagulation on thrombopoietin release during endotoxemia. (2001) (32)
- Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism. (2006) (31)
- Platelet function under high‐shear conditions from platelet concentrates (2007) (31)
- Ethnic differences in plasma levels of interleukin-8 (IL-8) and granulocyte colony stimulating factor (G-CSF). (2007) (31)
- Why have studies of tailored anti-platelet therapy failed so far? (2013) (31)
- Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. (2016) (31)
- Sublingual functional capillary rarefaction in chronic heart failure (2018) (30)
- Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up. (2010) (30)
- Effect of Intradermal Tumor Necrosis Factor-α-induced Inflammation on Coagulation Factors in Dermal Vessel Endothelium (2001) (30)
- Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. (1996) (30)
- Human monocyte stimulation by experimental whole body hyperthermia. (2002) (30)
- Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil‐platelet aggregates (1999) (30)
- Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men. (2001) (30)
- Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial. (2017) (29)
- Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. (1996) (29)
- Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation. (2002) (29)
- Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing (2018) (29)
- Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence (2018) (29)
- High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis (2001) (29)
- The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer (2020) (28)
- Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings. (1997) (28)
- Reversal strategy in antagonizing the P2Y12‐inhibitor ticagrelor (2013) (28)
- Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin‐induced acute inflammation in humans (2003) (28)
- Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates (2003) (28)
- Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study. (2018) (28)
- In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model (2008) (27)
- Sex differences in the association between albumin and all‐cause and vascular mortality (2009) (27)
- THE TUMOR NECROSIS FACTOR &agr; −308 G/A POLYMORPHISM DOES NOT INFLUENCE INFLAMMATION AND COAGULATION RESPONSE IN HUMAN ENDOTOXEMIA (2007) (27)
- Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers (2019) (27)
- Influence of the Duffy Antigen on Pharmacokinetics and Pharmacodynamics of Recombinant Monocyte Chemoattractant Protein (MCP-1, CCL-2) in Vivo (2009) (27)
- The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. (2006) (27)
- Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen. (1998) (27)
- Quantification of human diamine oxidase. (2017) (27)
- Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation* (2009) (26)
- Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. (2000) (26)
- Interplay between Genetic and Clinical Variables Affecting Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention (2014) (26)
- Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial. (2012) (26)
- The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. (2005) (26)
- A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea. (2014) (25)
- Combined integrated protocol/basket trial design for a first-in-human trial (2016) (25)
- Colistin Reduces LPS‐Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled Trial (2017) (25)
- Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients (2019) (25)
- Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway. (1997) (25)
- Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients (2020) (24)
- LPS-induced microvascular leukocytosis can be assessed by blue-field entoptic phenomenon. (2004) (24)
- In vitro platelet function of platelet concentrates prepared using three different apheresis devices determined by impedance and optical aggregometry (2009) (24)
- Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia (2003) (24)
- Cold agglutinin disease: current challenges and future prospects (2019) (24)
- Specific inhibition of the classical complement pathway prevents C3 deposition along the dermal-epidermal junction in bullous pemphigoid. (2019) (24)
- Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐Dimer analysis: A prospective study (2020) (24)
- Endotoxin Down-Modulates P-Selectin Glycoprotein Ligand-1 (PSGL-1, CD162) on Neutrophils in Humans (2004) (24)
- A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate. (2012) (23)
- Reparixin, a Specific Interleukin-8 Inhibitor, Has No Effects on Inflammation during Endotoxemia (2007) (23)
- Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men (2016) (23)
- Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial (2011) (22)
- A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis. (2012) (22)
- Product review on the JE vaccine IXIARO (2015) (22)
- Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis (1998) (22)
- Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men. (2000) (22)
- Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood (2013) (22)
- Plasma Levels of Activated Factor VII Decrease during the Menstrual Cycle (1998) (22)
- Early Effects of Paroxetine on Serotonin Storage, Plasma Levels, and Urinary Excretion: A Randomized, Double-Blind, Placebo-Controlled Trial (2004) (22)
- Effects of granulocyte colony stimulating factor on retinal leukocyte and erythrocyte flux in the human retina. (2002) (22)
- Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. (2016) (21)
- Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100 (2000) (21)
- Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study. (2019) (21)
- Clopidogrel in Critically Ill Patients (2017) (21)
- Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. (2020) (21)
- Granulocyte colony‐stimulating factor (G‐CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans (2000) (21)
- The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. (2011) (21)
- Dissociation between systemic and pulmonary anti‐inflammatory effects of dexamethasone in humans (2016) (20)
- Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. (2006) (20)
- Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial. (2016) (20)
- Ticagrelor: from discovery to Phase III clinical trial. (2010) (20)
- An update on the clinical evidence that supports biosimilar approvals in Europe (2018) (20)
- Chondroitin Sulfate N‐acetylgalactosaminyltransferase‐1 (CSGalNAcT‐1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity (2017) (20)
- Clinical trials for authorized biosimilars in the European Union: a systematic review (2016) (20)
- Characterization of recombinant human diamine oxidase (rhDAO) produced in Chinese Hamster Ovary (CHO) cells. (2016) (19)
- Glycocalyx as Possible Limiting Factor in COVID-19 (2021) (19)
- ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo (2021) (19)
- Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial (2015) (19)
- Response to Letter by van Werkum: Proton pump inhibitors and clopidogrel: a difficult dilemma (2009) (19)
- Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial (2022) (19)
- Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects (2016) (19)
- Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man. (2000) (19)
- Synergistic antiplatelet effects of clopidogrel and aspirin detected with the PFA-100 in stroke patients. (2003) (19)
- MMP-8 Genotypes Influence the Inflammatory Response in Human Endotoxemia (2013) (19)
- Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis (2021) (18)
- Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans (2010) (18)
- Recovery, safety, and tolerability of a solvent/detergent‐treated and prion‐safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers (2013) (18)
- Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy (2010) (18)
- Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism (2009) (18)
- Platelet activation at the onset of human endotoxemia is undetectable in vivo (2016) (18)
- Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation (2018) (18)
- Studying multiple protein profiles over time to assess biomarker validity (2006) (17)
- The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia (2005) (17)
- Rapid down modulation of P‐selectin glycoprotein ligand‐1 (PSGL‐1, CD162) by G–CSF in humans (2002) (17)
- The effect of erythropoietin on platelet and endothelial activation markers: A prospective trial in healthy volunteers (2012) (17)
- Disseminated intravascular coagulation in heat stroke: a hot topic. (2012) (17)
- Starting enteral nutrition with preterm single donor milk instead of formula affects time to full enteral feeding in very low birthweight infants (2017) (17)
- Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. (2016) (17)
- Antithrombotic therapy in special circumstances. II—In children, thrombophilia, and miscellaneous conditions (2003) (17)
- Heparin lowers plasma levels of activated factor VII (1999) (17)
- Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype (2021) (16)
- Procoagulant extracellular vesicles in amniotic fluid (2017) (16)
- Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis (2021) (16)
- Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men. (1997) (16)
- Effects of endothelin‐1 on circulating adhesion molecules in man (1997) (16)
- Dipyridamole Decreases Protease-Activated Receptor and Annexin-V Binding on Platelets of Poststroke Patients with Aspirin Nonresponsiveness (2006) (16)
- Age and sex modulate metabolic and cardiovascular risk markers of patients after 1 year of highly active antiretroviral therapy (HAART). (2006) (16)
- Granulocyte colony-stimulating factor (G-CSF) increases histone-complexed DNA plasma levels in healthy volunteers (2016) (16)
- Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis. (2020) (16)
- Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A (2020) (16)
- The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients (2020) (16)
- Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide (2005) (15)
- Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C (2005) (15)
- Immunomodulatory effects of fosfomycin in an endotoxin model in human blood. (2006) (15)
- The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo. (2007) (15)
- Anti Von Willebrand Factor Aptamer ARC 1779 for Refractory Thrombotic Thrombocytopenic Purpura. (2008) (15)
- Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa (2006) (15)
- Endotoxemia, inflammation, and atrial fibrillation. (2007) (15)
- Enalapril Does Not Alter Adhesion Molecule Levels in Human Endotoxemia (2003) (15)
- Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis (2022) (15)
- Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination (2021) (14)
- Prasugrel in critically ill patients (2017) (14)
- EFFECTS OF THE PAN-SELECTIN ANTAGONIST BIMOSIAMOSE (TBC1269) IN EXPERIMENTAL HUMAN ENDOTOXEMIA (2007) (14)
- The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin (2020) (14)
- Therapeutic approaches in the management of oral cyclosporine A intoxication. (2003) (14)
- Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial (2017) (14)
- Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin. (1997) (14)
- Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest (2018) (14)
- Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes – is there a future? (2009) (14)
- Kinetics of circulating selectin levels during bone marrow aplasia (1998) (14)
- Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study (2019) (14)
- Polymorphism in the tissue factor region is associated with basal but not endotoxin‐induced tissue factor‐mRNA levels in leukocytes (2006) (14)
- Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5 (2021) (14)
- Studies on the effect of short‐term oral dihydroergotamine and troxerutin in patients with varicose veins (1994) (14)
- Penetration of a Monoclonal Antibody Combination (ASN100) Targeting S. aureus Cytotoxins in Lung Epithelial Lining Fluid: A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Volunteers. (2019) (14)
- Antithrombotic therapy in special circumstances. I—pregnancy and cancer (2003) (14)
- Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by isocratic high-pressure liquid chromatography with post-column hydrolysis and fluorescence detection. (2013) (14)
- Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants (2020) (13)
- Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. (2020) (13)
- Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study. (2019) (13)
- Erythropoietin Treatment Is Associated with More Severe Thrombocytopenia in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy (2006) (13)
- Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200 (2020) (13)
- Myeloid but not epithelial tissue factor exerts protective anti‐inflammatory effects in acid aspiration‐induced acute lung injury (2017) (13)
- Validation of a novel tissue factor assay in experimental human endotoxemia. (2003) (13)
- Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure. (2021) (13)
- Statistical analysis of Goal Attainment Scaling endpoints in randomised trials (2018) (13)
- Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo‐Controlled, Double‐blind Trial (2006) (13)
- Effects of nitroglycerin and sodium nitroprusside on endexpiratory concentrations of nitric oxide in healthy humans. (1998) (12)
- Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results (2022) (12)
- Rofecoxib exerts no effect on platelet plug formation in healthy volunteers. (2003) (12)
- Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: A double blind randomized placebo controlled trial (2009) (12)
- Immunoglobulin administration to fetuses with anemia due to alloimmunization to D (1999) (12)
- Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow (2016) (12)
- Vaccine against toxic shock syndrome in a first-in-man clinical trial (2017) (12)
- Potential biomarkers of an exaggerated response to endotoxemia (2007) (12)
- Added value of the DIC score and of D-dimer to predict outcome after successfully resuscitated out-of-hospital cardiac arrest. (2018) (12)
- A Novel Diagnostic and Prognostic Score for Abdominal Aortic Aneurysms Based on D-Dimer and a Comprehensive Analysis of Myeloid Cell Parameters (2019) (12)
- Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study (2021) (12)
- Decreased renal function in hypertensive emergencies (2014) (12)
- Sublingual microvasculature in diabetic patients. (2019) (12)
- Absorption kinetics of low‐dose chewable aspirin – implications for acute coronary syndromes (2015) (11)
- Functional capillary impairment in patients with ventricular assist devices (2019) (11)
- Effects of testosterone suppression on serum levels of hepatitis B surface antigen and HBV-DNA in men. (2008) (11)
- Current developments in anti-platelet therapy (2006) (11)
- Endotoxemia enhances circulating endothelial cells in humans (2006) (11)
- An experimental model to study isolated effects of thrombin in vivo. (2010) (11)
- Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation. (2000) (11)
- Pharmacokinetics and Pharmacodynamics of the Dual FII/FX Inhibitor BIBT 986 in Endotoxin‐induced Coagulation (2007) (11)
- Strain differences in toxic effects of long-lasting isoflurane anaesthesia between Wistar rats and Sprague Dawley rats. (2008) (11)
- Acute effects of hyperglycaemia on plasma concentration of soluble P-selectin and von Willebrand factor in healthy volunteers -a prospective randomised double blind controlled study. (2009) (11)
- Evaluation of anti-inflammatory and anti-adhesive effects of heparins in human endotoxemia (2002) (10)
- Factor V Leiden mutation enhances fibrin formation and dissolution in vivo in a human endotoxemia model. (2010) (10)
- Sutimlimab for treatment of cold agglutinin disease: why, how and for whom? (2022) (10)
- Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective (2010) (10)
- The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references. (2008) (10)
- Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients (2017) (10)
- Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase (2017) (10)
- Clinical Experience With Numeta in Preterm Infants: Impact on Nutrient Intake and Costs. (2016) (10)
- Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration. (2005) (10)
- Biometry of the corpus callosum assessed by 3D ultrasound and its correlation to neurodevelopmental outcome in very low birth weight infants (2017) (10)
- Safety of a universal, virus‐inactivated and prion‐depleted, pharmaceutical‐quality plasma: a randomized, double‐blind, clinical trial in healthy volunteers (2011) (10)
- Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines. (2020) (10)
- In Vivo Study of the Effect of Exogenous Estradiol on α-Adrenoceptor Responsiveness of Human Veins (1994) (10)
- Effects of sodium nitroprusside on hemodialysis-induced platelet activation. (1999) (10)
- Sex differences in circulating P-selectin, E-selectin and thrombomodulin. (1996) (10)
- Top‐down proteomic analysis by MALDI‐TOF profiling: Concentration‐independent biomarkers (2008) (10)
- Prognosis of overt disseminated intravascular coagulation in patients admitted to a medical emergency department (2017) (10)
- Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S. (2010) (10)
- Interleukin-6 in acute coronary syndrome is a powerful predictor of long-term cardiovascular mortality. (2020) (9)
- Establishment of a Low Dose Canine Endotoxemia Model to Test Anti-Inflammatory Drugs: Effects of Prednisolone (2013) (9)
- Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon. (2016) (9)
- Growth, Feeding Tolerance and Metabolism in Extreme Preterm Infants under an Exclusive Human Milk Diet (2019) (9)
- Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans. (2000) (9)
- Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM) (2017) (9)
- The ISTH DIC score predicts outcome in non-septic patients admitted to a cardiovascular intensive care unit. (2020) (9)
- Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level. (2005) (9)
- Tolerability and pharmacokinetics of inhaled bimosiamose disodium in healthy males. (2007) (9)
- Does acute alcohol intoxication cause transaminase elevations in children and adolescents? (2016) (9)
- High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction (2020) (8)
- A MicroRNA Next-Generation-Sequencing Discovery Assay (miND) for Genome-Scale Analysis and Absolute Quantitation of Circulating MicroRNA Biomarkers (2022) (8)
- Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial. (2017) (8)
- Colistin dampens fibrinolysis and endothelial activation during endotoxaemia (2017) (8)
- Dexamethasone inhibits endotoxin‐induced coagulopathy in human lungs (2016) (8)
- Demonstration of Clinical Comparability of the Biosimilar Filgrastim to Neupogen, in Terms of Safety and Efficacy, in Healthy Volunteers and Patients Receiving Myelosuppressive Chemotherapy (2014) (8)
- High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 (2021) (8)
- Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effects (2015) (8)
- Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers (2018) (8)
- A new flow cytometric method for simultaneous measurement of residual platelets and RBCs in plasma: validation and application for QC (2001) (8)
- First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers (2022) (8)
- COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria (2021) (7)
- Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome plus CML (2014) (7)
- Increased Citrullinated Histone H3 Levels in the Early Post-Resuscitative Period Are Associated with Poor Neurologic Function in Cardiac Arrest Survivors—A Prospective Observational Study (2019) (7)
- Aspirin. Methods to assess aspirin resistance. (2004) (7)
- The use of frozen plasma samples in thromboelastometry (2017) (7)
- Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials (2022) (7)
- The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model (2009) (7)
- Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation (2007) (7)
- Genetic variations and their influence on risk and treatment of venous thrombosis. (2008) (7)
- Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention (2017) (7)
- The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients (1999) (7)
- Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state (2019) (7)
- Androgen deprivation decreases prostate specific antigen in the absence of tumor: implications for interpretation of PSA results (2013) (7)
- Routine haematological parameters in COVID-19 prognosis (2020) (7)
- von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo (2020) (7)
- Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact‐R (2009) (7)
- Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism (2021) (7)
- Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients (2020) (6)
- Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12 -inhibition after ticagrelor intake. (2013) (6)
- Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK. (2005) (6)
- Sample Size for Multiple Hypothesis Testing in Biosimilar Development (2018) (6)
- The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial (2021) (6)
- Recombinant human diamine oxidase activity is not inhibited by ethanol, acetaldehyde, disulfiram, diethyldithiocarbamate or cyanamide. (2016) (6)
- Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C (2006) (6)
- Response to vWF‐coated beads and soluble p‐selectin to characterize apheresis platelets: a comparison of three cell separators (2002) (6)
- Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings (2014) (6)
- Microarray-based Detection of Allergen-Reactive IgE in Patients with Mastocytosis. (2020) (6)
- Identification of a novel exon encoding the amino-terminus of the predominant caspase-5 variants. (2006) (6)
- Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome (2020) (6)
- Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers (2019) (6)
- DESMOPRESSIN AND PLATELETS ANTAGONIZE THE IN VITRO PLATELET DYSFUNCTION INDUCED BY GPIIb / IIIa INHIBITORS AND ASPIRIN 1 (2003) (6)
- Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis (2021) (6)
- Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane Oxygenation (2021) (6)
- Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open‐label, extension trial (2022) (6)
- Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical (2021) (6)
- Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19—A Prospective Observational Longitudinal Study (2021) (5)
- Cardiovascular Scoring and Age-Related Mutations Predict the Occurrence of Adverse Vascular Events in CML Patients during Nilotinib Therapy (2017) (5)
- Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death. (2020) (5)
- A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation (2021) (5)
- Therapeutic failure or resistance to aspirin. (2004) (5)
- Comparison of a new ELISA‐based with the flow cytometric assay for vasodilator‐associated stimulated phosphoprotein phosphorylation to assess P2Y12‐inhibition after ticagrelor intake (2013) (5)
- Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia (2017) (5)
- Acetylsalicylic acid in critically ill patients: a cross‐sectional and a randomized trial (2017) (5)
- The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers (2007) (5)
- Platelets and new antiplatelet drugs (2005) (5)
- Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study (2021) (5)
- The effect of plasma removal from apheresis platelet concentrates on platelet function (2012) (5)
- Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo (2020) (5)
- Sunday, 26 August 2012 (2012) (5)
- Tecarfarin: A Novel Vitamin K Antagonist (2017) (5)
- Dexamethasone Downregulates l-Selectin In Vitro and In Vivo (1998) (5)
- ELBW infants receive inadvertent sodium load above the recommended intake (2020) (5)
- A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation (2022) (5)
- Continuous thrombin infusion leads to a bleeding phenotype in sheep. (2012) (5)
- Limitations of a calibrated, quantitative APC‐R assay under routine conditions (2020) (5)
- ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. I—pregnancy and cancer (2003) (4)
- The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin (2019) (4)
- Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications (2022) (4)
- Interference in specialized coagulation assays affecting the protein C pathway: Effects of marked haemolysis, hyperbilirubinaemia and lipaemia on chromogenic and clotting tests on two coagulation platforms (2019) (4)
- Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial (2021) (4)
- Clinical pharmacology of antiplatelet drugs (2022) (4)
- Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial (2020) (4)
- Platelet function in mitochondriopathy with stroke and stroke-like episodes (2004) (4)
- Serum and Lung Pharmacokinetics of ASN100, a Monoclonal Antibody Combination for the Prevention and Treatment of Staphylococcus aureus Pneumonia (2017) (4)
- Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial (2022) (4)
- The association of the Thr715Pro P‐selectin genotype with levels of P‐selectin in platelet concentrates (2014) (4)
- Development of Advanced Therapy Medicinal Products: A Case for Early Scientific Advice (2010) (4)
- Does Phosphodiesterase III Inhibition Reverse the Cardiodepressive Effects of Propofol? (1997) (4)
- Simple, sensitive and specific quantification of diamine oxidase activity in complex matrices using newly discovered fluorophores derived from natural substrates (2020) (4)
- Development and external validation of a logistic regression derived formula based on repeated routine hematological measurements predicting survival of hospitalized Covid-19 patients (2020) (4)
- Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation. (2002) (4)
- A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial (2019) (4)
- A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP) (2010) (4)
- False‐positive pregnancy test after transfusion of solvent/detergent‐treated plasma (2017) (4)
- Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial. (2020) (4)
- Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention (2014) (4)
- Female gender, menstrual cycle and estradiol affect plasma levels of monocyte chemotactic protein-1 (MCP-1) in humans. (2002) (4)
- High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm (2020) (4)
- Man, mouse and Duffy genotype–phenotype‐specific pharmacokinetics of monocyte chemotactic protein‐1 (2004) (4)
- Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials? (2021) (4)
- Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study. (2017) (4)
- Pharmacokinetic Modeling of Morphine’s Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers (2021) (4)
- Regulation of histamine and diamine oxidase in patients undergoing orthotopic liver transplantation (2020) (3)
- Prolonged Activated Partial Thromboplastin Time after Successful Resuscitation from Cardiac Arrest is Associated with Unfavorable Neurologic Outcome (2020) (3)
- The platelet α2-integrin (GPIa) nucleotide-807 polymorphism is not associated with a risk for maternal–fetal human platelet antigen-5 incompatibility (2000) (3)
- Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial (2020) (3)
- Antithrombin for severe sepsis? Try it again, but without heparin! (2006) (3)
- Protease-Activated Receptors 1 and 3 are Differentially Expressed on Human Monocyte Subsets and are Upregulated by Lipopolysaccharide Ex Vivo and In Vivo (2019) (3)
- Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe? (2018) (3)
- In vivo profile of the human leukocyte microRNA response to endotoxemia (2008) (3)
- LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans (2018) (3)
- Monitoring of ADAMTS13 in Patients with Thrombotic Thrombocytopenic Purpura: Prediction of Response to Therapy, Risk of Relapse, and Long- Term Outcome. (2008) (3)
- Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9‐mediated dose requirements of vitamin K antagonist therapy: a pilot study (2014) (3)
- 588 Optimization of schedule, route and adjuvant of therapeutic peptide vaccines against HCV (2006) (3)
- PCSK9 decreases during experimental endotoxemia (2020) (3)
- Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometry (2015) (3)
- Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemia (2017) (3)
- Can Sequential Coagulation Monitoring Predict Major Haemorrhage in Extremely Low Birth Weight Infants? (2018) (3)
- [Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants]. (2014) (3)
- Microvascular rarefaction in patients with cerebrovascular events (2021) (3)
- Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: A systematic review and meta-analysis. (2021) (3)
- Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study (2021) (3)
- Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product (2017) (3)
- Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections (2020) (3)
- Condensation of delta‐1‐piperideine‐6‐carboxylate with ortho‐aminobenzaldehyde allows its simple, fast, and inexpensive quantification in the urine of patients with antiquitin deficiency (2020) (3)
- Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in Type II diabetic patients suffering from microalbuminuria (1998) (3)
- [605] THERAPEUTIC PEPTIDE VACCINATION AGAINST CHRONIC HEPATITIS C VIRUS INFECTION (2007) (3)
- Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood (2010) (3)
- Ristocetin-Induced Platelet Aggregation for Monitoring of Bleeding Tendency in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia (2015) (3)
- Safety of endotoxin challenge in healthy volunteers: bradycardia (2005) (2)
- EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS (2007) (2)
- Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis. (2017) (2)
- Platelet glycoprotein Ibα polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease (2007) (2)
- Thrombopoiesis Is Increased in Hyperthyroidisme (1998) (2)
- Change of Hemoglobin Levels in the Early Post-cardiac Arrest Phase Is Associated With Outcome (2021) (2)
- Effects of enalapril on disseminated intravascular thrombin formation during systemic inflammation. (2003) (2)
- Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients? (2021) (2)
- Randomized Controlled Trial of Two Timepoints for Introduction of Standardized Complementary Food in Preterm Infants (2022) (2)
- The systemic renin-angiotensin system in COVID-19 (2022) (2)
- Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level (2022) (2)
- Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease (2022) (2)
- Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia (2019) (2)
- Low PCSK-9 levels Are Associated with Favorable Neurologic Function after Resuscitation from out of Hospital Cardiac Arrest (2020) (2)
- The Toll-Like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms Influence the Late Inflammatory Re- sponse in Human Endotoxemia, (2005) (2)
- "Advances in thrombosis and haemostasis". (2003) (2)
- DIC score predicts mortality in massive clot coagulopathy as a result of extensive pulmonary embolism: reply to a rebuttal (2010) (2)
- Regional cortical development in very low birth weight infants with normal neurodevelopmental outcome assessed by 3D-ultrasound (2013) (2)
- APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke (2023) (2)
- Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT) (2022) (2)
- Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422) (2022) (2)
- The Thr715Pro single nucleotide polymorphism of P-selectin: does it really matter in cardiovascular or thrombotic disorders? (2004) (2)
- Safety and Efficacy of the C1S Complement Inhibitor TNT009 in a FIRST-In-Human Trial (2017) (2)
- Admission C-reactive protein concentrations are associated with unfavourable neurological outcome after out-of-hospital cardiac arrest (2021) (2)
- Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression (2003) (2)
- ANTI-IL-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – MOLECULAR REBOUND PHENOMENA UNDER IL-6 BLOCKADE? (2020) (2)
- Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study (2022) (2)
- LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 Cells (2018) (2)
- Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state (2019) (2)
- Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up (2020) (2)
- Morphine decreases ticagrelor concentrations but not its effects: a randomized, double-blind, placebo-controlled trial (2015) (2)
- “Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction”: study protocol for a randomized controlled trial (2020) (2)
- Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD) (2016) (2)
- The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease (2022) (2)
- The Anti Von Willebrand Factor Aptamer ARC1779 Prevents the Desmopressin-Induced Thrombocytopenia in VWD Type 2B. (2008) (1)
- The EGF A61G polymorphism is associated with shorter disease-free period and survival in malignant melanoma (2006) (1)
- Dexamethasone downregulates L-selectin in vitro and in vivo. (1998) (1)
- Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis. (2021) (1)
- von Willebrand Factor-binding aptamer rondoraptivon pegol as treatment for severe and non-severe hemophilia A. (2022) (1)
- Heparin Blunts LPS-Induced Coagulation Activation Pernerstorfer (1999) (1)
- GPIIb/IIIa inhibitors and aspirin Desmopressin antagonizes the in vitro platelet dysfunction induced by (2011) (1)
- P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396) (2022) (1)
- Functional Role of the Chemokine Binding Duffy Antigen Receptor Complex (DARC) in Human Inflammation In Vivo. (2006) (1)
- Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort study. (2016) (1)
- Therapeutic Rationale and Clinical Development of TNT009, an Upstream Classical Pathway Inhibitor, for Cold Agglutinin Disease (2015) (1)
- Soluble P-selectin in Diabetes (1999) (1)
- Minimizing disasters during early drug development: A pressing need for an improved guidance (2006) (1)
- Correction: Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial (2017) (1)
- The Effect of BIBT 986, a Novel Small Molecule Dual Inhibitor of Thrombin and Factor Xa, on Coagulation in a Model of Endotoxin Induced, Tissue Factor Triggered Coagulation Activation in Humans. (2006) (1)
- The Aptamer ARC1779 Potently and Specifically Inhibits the Excessive von Willebrand Factor (vWF) Activity and vWF-Mediated Ex Vivo Platelet Function of Patients with Thrombotic Thrombocytopenic Purpura (TTP). (2007) (1)
- TNT009, a monoclonal antibody inhibitor of C1s, induces a rapid and complete remission of anemia in primary cold agglutinin disease patients (2016) (1)
- Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid (2022) (1)
- PII‐60 (2006) (1)
- Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis (2010) (1)
- Phase I Studies and First-In-Human Trials (2016) (1)
- Add-on Prostaglandin E1 in Venovenous Extracorporeal Membrane Oxygenation: A Randomized, Double-blind, Placebo-controlled Pilot Trial. (2022) (1)
- Thrombopoiesis is increased in hyperthyroidism. (1998) (1)
- A randomized controlled trial on the effects of adding vitamin B 12 and folate (2006) (1)
- S900 EVIDENCE BASED USE OF ERYTRHOPOIETIN IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA: A MULTICENTER INTERNATIONAL STUDY (2019) (1)
- Surface cooling for induction of mild hypothermia in conscious healthy volunteers (2010) (1)
- Plasma Proteome Profiling: Widespread Oxidative Changes in Endotoxemia Correlate with Intravascular Tissue Factor Response. (2004) (1)
- Strong Correlation of High Endogenous Plasma Levels of Tissue Factor Pathway Inhibitor (TFPI) with Poor Blood Clotting and Corrective Action of BAX 513 Under FVIII-Inhibited Conditions (2011) (1)
- Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration (2022) (1)
- Massive release of Th2 cytokines induced a cytokine storm during a severe mast cell activation event in an indolent systemic mastocytosis patient. (2022) (1)
- Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial (2022) (1)
- A model comparing how rapidly transfusion of solvent detergent plasma restores clotting factors versus infusion of albumin-saline. (2015) (1)
- Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial. (2022) (1)
- Pharmacodynamics (PD) of clopidogrel in patients with acute coronary syndromes undergoing percutaneous interventions (PCI) (2005) (1)
- 353Evaluation of the pharmacokinetics and pharmacodynamics of subcutaneously administered dutogliptin for daily injection with granulocyte colony stimulating factor (G-CSF) for AMI (2018) (1)
- Human diamine oxidase cellular binding and internalization in vitro and rapid clearance in vivo are not mediated by N-glycans but by heparan sulfate proteoglycan interactions. (2020) (1)
- Influence of tiapride on platelet counts in healthy volunteers and patients with movement disorders (2003) (1)
- Preterm Infants on Early Solid Foods and Iron Status in the First Year of Life—A Secondary Outcome Analysis of a Randomized Controlled Trial (2022) (0)
- Su.56. Optimization of Schedule, Route and Adjuvant of Therapeutic Peptide Vaccines Against Hcv (2006) (0)
- Influence of the Duffy genotype on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1) in vivo (2007) (0)
- Glycosylation site Asn168 is important for slow in vivo clearance of recombinant human diamine oxidase heparin-binding motif mutants. (2022) (0)
- associated with enhanced coagulation during human endotoxemia The single nucleotide polymorphism Ser128Arg in the E-selectin gene is (2013) (0)
- Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria (2021) (0)
- Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing (2018) (0)
- Corrigendum to “Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion” [Ann Thorac Surg 91 (2011) 1420-1426] (2020) (0)
- Su1722 Risk Factors Cannot Explain the Sex Specific Difference in Detection Rates of Colorectal Adenomas and Advanced Adenomas (2016) (0)
- Human diamine oxidase is readily released from activated neutrophils ex vivo and in vivo but is rarely elevated in bacteremic patients (2020) (0)
- Effects of Indomethacin on the l‐selectin Expression in Humans (2001) (0)
- Reversal Strategy For Antagonizing The P2Y12-Inhibitor Ticagrelor By Platelet Concentrates (2013) (0)
- Prolonged antithrombotic therapy in patients after acute coronary syndrome - a critical appraisal of current ESC guidelines (2020) (0)
- Monitoring platelet activation with two different shear-dependent function tests: application of PFA-100 and the Impact-R ARA (2007) (0)
- The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor-mediated ex vivo platelet function in ST-elevation and non-ST-elevation acute myocardial infarction (2008) (0)
- Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine (2022) (0)
- Abstract 10981: Morphine Decreases Clopidogrel Concentrations and Effects: a Randomized, Double Blind, Placebo-Controlled Trial (2013) (0)
- Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology (2015) (0)
- Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (2023) (0)
- S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY (2022) (0)
- S905 LONG TERM INHIBITION OF COMPLEMENT C1S IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM A NAMED PATIENT PROGRAM (2019) (0)
- Preterm Infants on Early Solid Foods and Vitamin D Status in the First Year of Life—A Secondary Outcome Analysis of a Randomized Controlled Trial (2022) (0)
- Quality criteria for Real-World Data in pharmaceutical research and healthcare decision making. An Austrian Expert Consensus (Preprint) (2021) (0)
- Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients, (2011) (0)
- New Technologies, Diagnostic Tools and Drugs (2009) (0)
- MMP-8 Genotypes Influence the Inflammatory Response in Human Endotoxemia (2013) (0)
- Homozygosity in the Single Nucleotide Polymorphism Ser128Arg in the E-Selectin Gene Is Associated with Recurrent Venous Thromboembolism. (2006) (0)
- Methylnaltrexone to Reduce the Inhibitory Effects of Opioids on Drug Absorption. (2019) (0)
- Nilotinib exerts proatherogenic and growth-inhibitory effects on endothelial cells: a potential mechanism underlying drug-related vasculopathy in Ph plus CML (2014) (0)
- Nilotinib-induced vasculopathy : identification of vascular 1 endothelial cells as a primary target site 2 3 4 (2017) (0)
- Monoclonal antibodies for treatment of cold agglutinin disease. (2023) (0)
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip (2021) (0)
- Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader (2021) (0)
- Surface cooling in combination with magnesium sulfate for induction of mild hypothermia in conscious healthy volunteers has only minor effect on platelet aggregation (2010) (0)
- Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study (2022) (0)
- Creation of a local 'fever' using an infrared lamp to cure a tooth abscess (2006) (0)
- Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers (2023) (0)
- Regulation of histamine and diamine oxidase in patients undergoing orthotopic liver transplantation (2020) (0)
- P668Aspirin for primary prevention of cardiovascular disease (2019) (0)
- An improved diagnostic score for abdominal aortic aneurysms based on a comprehensive analysis of myeloid cell parameters (2018) (0)
- European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. (2023) (0)
- EFFECT OF PROTON PUMP INHIBITORS ON CLINICAL OUTCOME IN PATIENTS TREATED WITH CLOPIDOGREL: A SYSTEMATIC REVIEW AND META-ANALYSIS (2010) (0)
- Corrigendum to "Characterization of recombinant human diamine oxidase (rhDAO) produced in Chinese Hamster Ovary (CHO) cells" [J. Biotechnol. 227 (2016) 120-130]. (2016) (0)
- Sutimlimab Provides Sustained Improvements in Patient-Reported Outcomes and Quality of Life in Patients with Cold Agglutinin Disease: Open-Label Extension of the Randomized, Phase 3 Cadenza Study (2022) (0)
- Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1 (2023) (0)
- Functional capillary impairment in patients with ventricular assist devices (2019) (0)
- Mechanism of action of drotrecogin alfa activated (rhAPC) (2004) (0)
- TNT009 Prevents Erythrocyte C3 Fragment Opsonization and Rescues Reticulocytes from Destruction in Patients with Cold Agglutinin Disease (2016) (0)
- 985: DEXAMETHASONE REDUCES SYSTEMIC INFLAMMATION BUT ONLY MINIMALLY DECREASES INTERLEUKIN-6 SECRETION INTO LUNG FOLLOWING BRONCHIAL ENDOTOXIN INSTILLATION TO HEALTHY VOLUNTEERS (2012) (0)
- Aspirin (2004) (0)
- 960: DEXAMETHASONE INHIBITS ENDOTOXIN-INDUCED CLOTTING BY BLUNTING PROTEIN EXTRAVASATION IN HUMAN LUNGS (2016) (0)
- THREE-MONTH RESULTS OF A PHASE 2 TRIAL EVALUATING CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – EARLY IMPACT OF IL-6 BLOCKADE ON DONOR-SPECIFIC ANTIBODY LEVELS, REJECTION MORPHOLOGY AND GENE EXPRESSION (2020) (0)
- Surrogate markers to monitor efficacy of anticoagulants or antiplatelet drugs in atrial fibrillation. (2002) (0)
- New drugs and directions (2005) (0)
- Highly Procoagulant Extracellular Vesicles in Amniotic Fluid (2016) (0)
- Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena (2022) (0)
- Granulocyte colony-stimulating factor and cytokine release. (2000) (0)
- Leukocyte scintigraphy with 99mTc-exametazime-labeled leukocytes is not useful for follow-up of systemic vasculitis. (2002) (0)
- Effect of therapeutic mild hypothermia initiated by cold fluids after cardiac arrest on haemostasis as measured by thrombelastography (2008) (0)
- Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia (2018) (0)
- Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia (2017) (0)
- P531Mitochondria of parental cells control the capacity of monocyte-derived microvesicles to activate endothelial cells (2018) (0)
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study (2021) (0)
- “Low-Level” Carbon Monoxide Administration May Carry Risk (2005) (0)
- WITHDRAWN: Extraordinary apolipoprotein oxidation in chronic hepatitis C and liver cirrhosis. (2007) (0)
- Inflammatory Conditions Migration Inhibitory Factor Ameliorates Conformational Isoform of Macrophage Selective Targeting of a Disease-Related (2015) (0)
- Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10 (2022) (0)
- Delayed effect of desmopressin on circulating neutrophils and monocytes. (1996) (0)
- Response to Letter by Tho (2009) (0)
- Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib on Endothelial Cells: A Potential Mechanism to Explain Vasculopathies in Cml Patients Treated With Nilotinib (2014) (0)
- Trial in Progress: Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Cold Agglutinin Disease (CASCADE) (2022) (0)
- Myeloid but not epithelial tissue factor exerts protective anti-inflammatory properties in acid aspiration-induced acute lung injury. (2017) (0)
- 2.P.362 Morning hypercoagulability and hypofibrinolysis: diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor-complex (1997) (0)
- Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK‐9 Concentrations in Healthy Subjects in a Double‐Blind, Randomized, Active‐Controlled, Crossover Trial (2022) (0)
- Effect of endotoxin on retinal erythrocyte and leukocyte flux in healthy humans. (2004) (0)
- Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial (2011) (0)
- Characterization of recombinant human diamine oxidase produced in Chinese Hamster Ovary cells (2016) (0)
- Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo (1994) (0)
- Hyperthyroidism enhances platelet plug formation (2006) (0)
- Abstract 12868: Morphine Decreases Ticagrelor Concentrations but Not Its Effects: A Randomized, Double-Blind, Placebo-Controlled Trial (2015) (0)
- Author Correction: Admission C-reactive protein concentrations are associated with unfavourable neurological outcome after out-of-hospital cardiac arrest (2021) (0)
- that demarginate during acute maximal exercise Expression of the cell adhesion molecules on leukocytes (2015) (0)
- Author response: Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical (2021) (0)
- Biomarkers for differentiation of coronavirus disease 2019 or extracorporeal membrane oxygenation related inflammation and bacterial/fungal infections in critically ill patients: A prospective observational study (2022) (0)
- Correction (1989) (0)
- P176An improved diagnostic score for abdominal aortic aneurysms based on a comprehensive analysis of myeloid cell parameters (2018) (0)
- Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysis in vitro (2018) (0)
- PP078—Comparison of a new elisa-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12-inhibition after ticagrelor intake (2013) (0)
- Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis (2023) (0)
- 1293: TRANEXAMIC ACID RESTORES CLOTTING IN THROMBUS ASSOCIATED HYPERFIBRINOLYSIS WITH OVERT BLEEDINGS (2014) (0)
- Adenosine diphosphate induced platelet aggregation is markedly increased in patients with ischemia-triggered cardiac arrest achieving ROSC (2010) (0)
- Natural IgM Against Oxidation-Specific Epitopes Inhibit Microvesicle-Driven Coagulation (2016) (0)
- Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent (2013) (0)
- Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease. (2022) (0)
- Multi-phasic life-threatening anaphylaxis refractory to epinephrine managed by extracorporeal membrane oxygenation (ECMO): A case report (2022) (0)
- 445 Function and phenotype of peptide-vaccine induced HCV specific CD8+ T cells vs. acute and chronic hepatitis C (2006) (0)
- Corrigendum to “Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion” [Ann Thorac Surg 91 (2011) 1420-1426] (2020) (0)
- Abstract 2223: Shear Induced Platelet Function Is Highly Increased In Patients With Cardiac Arrest Undergoing Cardio-pulmonary Resuscitation (CPR) (2007) (0)
- Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus (2021) (0)
- P1665: WHOLE-BLOOD ROTATIONAL THROMBOELASTOMETRY (ROTEM) AS A DIAGNOSTIC TOOL IN PATIENTS WITH BLEEDING OF UNKNOWN CAUSE (BUC) (2022) (0)
- Oc025—Reversal Strategy In Antagonizing The P2y12-Inhibitor Ticagrelor (2013) (0)
- VWF as a Prognostic Marker for Coronary Artery Disease in Initially Healthy Subjects (2008) (0)
- The Authors' reply (2011) (0)
- The Pharmacodynamic Effects of Rituximab at Very Low Doses (2017) (0)
- Long term immunogenicity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO®, IC51 (2010) (0)
- 453: MASSIVE BLEEDING ENSUES HYPERFIBRINOLYTIC DISSEMINATED INTRAVASCULAR COAGULATION IN DROWNING VICTIMS (2014) (0)
- Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism. (2021) (0)
- OC 025 — reVerSAl STrATegy iN ANTAgONiziNg The p 2 y 12-iNhibiTOr (2013) (0)
- A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT (2023) (0)
- Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials. (2023) (0)
- Extraordinary apolipoprotein oxidation in chronic and liver (2007) (0)
- LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans (2018) (0)
- Randomized, double-blind, placebo controlled trial of RHU-EPO to improve platelet count and platelet function in alcoholic cirrhotics with thrombocytopenia (2002) (0)
- Effect of the human endotoxin challenge on tedizolid tissue penetration (2022) (0)
- Diamine oxidase in pregnancy – An old acquaintance exclusively released from an unexpected source (2016) (0)
- Analysis of Aptamer Concentrations in Cynomolgus Macaque Plasma and in the Serum Stability Study (2012) (0)
- Anticoagulant and Anti-Inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge. (2005) (0)
- Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernd Jilma?
Bernd Jilma is affiliated with the following schools: